L’Huillier, Arnaud G.
Eshaghi, Alireza
Racey, C. Sarai
Ogbulafor, Katherene
Lombos, Ernesto
Higgins, Rachel R.
Alexander, David C.
Kristjanson, Erik
Maregmen, Jocelyn
Gubbay, Jonathan B.
Mazzulli, Tony
Article History
Received: 5 March 2018
Accepted: 1 May 2018
First Online: 5 June 2018
Ethics approval and consent to participate
: These data are also used for routine laboratory surveillance, which is a mandate of PHOL. Therefore, consultation with our organization’s privacy office or ethics committee was not required. To protect patient privacy and confidentiality, data are reported in an aggregated anonymized format.
: JB Gubbay has received research grants from GlaxoSmithKline Inc. and Hoffman-La Roche Ltd. to study antiviral resistance in influenza, and from Pfizer Inc. to conduct microbiological surveillance ofStreptococcus pneumoniae. The authors declare that they have no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.